Achieved 98% manufacturing batch success rate at BaseCamp across cell therapy, viral vector, and mRNA – Positioned U.S.-based biomanufacturing hub to supply genetic medicine products across North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback